Angel Investing Trends 2026: What Changes in Your Next Round
Larger angel cheques into fewer companies, life sciences near half of ACA-reported dollars: the angel investing trends of 2026 and what they change in a round.
ACA-reported angel investment rose 12% to $491.3M in 2025 as angel groups put more capital into each company they funded.
Individual angels typically write $25,000 to $100,000; a pooled syndicate puts its members into one vehicle and takes one line on the cap table.
Medical devices, pharma, digital health and diagnostics took nearly 47% of ACA-reported angel dollars in 2025, up from 31% in 2023.
AI-driven companies raised $102B of the $159B invested worldwide in Q3 2026, and 27 companies with $1B-plus rounds took around a third.
A lead investor checks pro rata rights, the SPV, the SAFE stack and side letters before it signs, so they're settled first.
The Angel Capital Association's 2026 Angel Funders Report sets out the angel investing trends of 2026: larger cheques into fewer companies, bigger follow-on commitments, a growing share of the dollars for life sciences, and an AI deal at nearly two-thirds of groups.
For a CEO or CFO with angels on the cap table and a fund about to price the next round, these trends arrive as two requests: angels already invested ask for their pro rata, and angels and syndicates from outside ask for a line.
Life sciences took 31% of ACA-reported angel dollars in 2023, 37% in 2024 and nearly 47% in 2025.
| Series | x | Value |
|---|---|---|
| Life sciences share | 2023 | 31% |
| Life sciences share | 2024 | 37% |
| Life sciences share | 2025 | 47% |
What are the angel investing trends in 2026?
ACA groups reported $491.3M invested in 2025, up 12% from $437M in 2024. That total is a sample of organised angel money.
For the whole market, the SEC's guide to early-stage investors cites angels putting over $17.9B into early-stage companies in 2024. Use the ACA series for direction and the SEC figure for size.
“Angel investors continue to fund innovation and support entrepreneurs, but they are doing so with greater discipline, stronger diligence practices, and a more deliberate approach to portfolio construction.”
PGPat GouhinCEO of the Angel Capital Association
Each row below comes from the ACA's 2026 report, with its effect on your round in the last column.
3 columns. Drag the table sideways; the first column stays put.
Trend | What the data shows | What it changes in your next round |
|---|---|---|
Larger cheques, fewer companies | More capital per investment and per company | Fewer angels, each with a bigger line and its own terms |
Follow-on grows | Follow-on investments draw larger commitments | Existing angels ask for their pro rata in the next round |
Hybrid groups | Groups that pair a network with a fund deploy more than traditional groups | One counterparty with fund paperwork, in place of many signatures |
Less governance | Angel governance participation keeps falling | Board influence moves to the lead fund |
How much do angel investors invest per deal?
Individual angels typically write $25,000 to $100,000, according to J.P. Morgan's angel financing guide, and the median US round that angels take part in has held near $250,000 for a decade on PitchBook data. The SEC puts an angel syndicate at $200,000 to $400,000 per deal.
| Row | Low end | High end |
|---|---|---|
| Individual angel (own money, one cheque) | $25K | $100K |
| Angel syndicate (pooled into one vehicle) | $200K | $400K |
Not every syndicate pools. A pooled one writes a single larger cheque, though J.P. Morgan notes the process can take longer because every participant has to sign off.
A deal-sourcing syndicate forwards the deal to its members instead, and the company collects several separate cheques.
Against a round a fund prices, each of these is a minority line on the lead's terms. Settling who leads and who follows comes before outreach starts, and it is the first job of a startup fundraising consultant on a priced round.
Where angels and syndicates sit in a priced round
J.P. Morgan describes the angel's job as getting a company to its first professional round, often led by institutional investors, and the SEC lists Series A among the rounds angels invest in. In that round four groups meet on one cap table.
How much do angel investors invest once a lead fund prices the round? Existing angels with a pro rata right can take up to their pro rata, enough to keep their percentage where it stood before the round. Anything above it, and any line for a new angel, is negotiated with the lead.
A pooled syndicate arrives as a special purpose vehicle (SPV), one company holding its members' money, so it takes one entry on the cap table however many angels stand behind it.
SAFEs (simple agreements for future equity) and convertible notes turn into shares in the round the lead prices, on their cap or discount.
| Step | Leads to |
|---|---|
| Lead fund (sets price and terms) | Priced round |
| Existing angels (take up their pro rata) | Priced round |
| Angel syndicate SPV (one line on the cap table) | Priced round |
| SAFEs and notes (convert in the priced round) | Priced round |
| Priced round (one set of documents) | Post-money cap table |
| Post-money cap table (every holder on one table) | end |
The lead's counsel puts each of the angel-side items below on its diligence list before the fund signs. Give every item an owner on your side: the CFO for the cap table, company counsel for the side letters.
3 columns. Drag the table sideways; the first column stays put.
Angel-side item | What the lead asks | When to fix it |
|---|---|---|
Pro rata rights | Who holds them, and how much each holder can take | Before the round is sized |
SPV manager and member list | Who signs for the SPV, and how fast | Before the term sheet |
SAFE and note stack | Caps, discounts, conversion order and the pro forma cap table | Before the first meeting |
Side letters | Any promise made outside the main documents | Before diligence opens |
Information rights | What angels receive after the round | In the term sheet |
Put every SAFE through a SAFE conversion calculator so the pro forma table already shows each one converted.
The lead wants all of this because it answers to its LPs for every line on the cap table, while an angel answers only to itself; the angel investor vs venture capitalist write-up covers that difference.
Which sectors are angel investors funding in 2026?
Sector is where the angel investing trends in the ACA's 2026 report move fastest. The report counts the rise of life sciences among its "most significant findings", led by medical devices, pharma and therapeutics, digital health and diagnostics. AI runs beside it: nearly two-thirds of reporting angel groups completed at least one AI-related investment in 2025, favouring applied AI, healthcare AI and industry-specific tools over foundational AI.
A software company outside AI, or a consumer brand, therefore meets a smaller pool of angels still writing in its sector. For a medical-device or diagnostics company the reverse holds: its sector already draws nearly half of reported angel dollars, and with follow-on commitments growing, those angels are likely to want a line in the next round too.
Venture capital trends 2026: where the money above the angel round goes
US venture proceeds rose from $212.9B in 2024 to $318.6B in 2025, second only to 2021's $358.5B, while the number of reported financings barely moved, 14,934 against 15,246, according to WilmerHale's 2026 Venture Capital Report.
With the count flat, the extra $105.7B went into bigger rounds, the pattern the angel investing trends show one stage earlier: a company that wins a lead raises more, and nobody else gets an extra slot.
In Crunchbase's Q3 2026 count, global venture funding reached $159B, AI-driven companies took $102B of it, and an all-time record of 27 companies raised rounds of $1B or more, taking around a third of the total. US companies took $91B, around 57% of it.
| Whole | Part | Share |
|---|---|---|
| Q3 2026, worldwide | AI-driven companies | 64% |
| Q3 2026, worldwide | All other companies | 36% |
Exits for angel and venture investors
Exits decide whether angels have money to recycle into follow-on, and in 2025 they came back. Wellington Management, writing on the Harvard Law School Forum on Corporate Governance, reported IPO volumes up 20% and proceeds up 84% in the 12 months before its December 2025 outlook, with secondary transactions projected above $210B for 2025.
WilmerHale counts 2025 venture-backed M&A value at more than triple the year before, past the 2021 record.
An early angel can also sell part of its stake inside your round, on the same term sheet: the new investor buys those shares beside the ones the company issues, the angel gets a partial exit, and the lead gets a larger stake without adding to the company's dilution.
From the desk. A $12M Series A for a robotics company in the United States, one of the startup rounds we have closed.
spectup has run 150+ mandates since 2022.
How spectup runs a round with angels already on the cap table
spectup acts for the company and brings the investors to the table, on mandates from Series A to pre-IPO. Series A is often the first round a fund prices, and the first time earlier angels face a lead's diligence. Plan on five to eight months from signing with us to the close.
Size the round. The milestone it funds, the amount, and each existing angel's pro rata, with every current investor listed on day one.
Build the materials. Deck, financial model and data room, including a pro forma cap table with each SAFE converted.
Draw up the lead list. Funds able to lead come first, taken from our own relationships and partner firms. Valicon.ai shows what each fund is writing into now, and our signal engine's read of fund activity sets when each one hears from us.
Run the outreach. New investors get warm introductions and signal-triggered outbound, in the order our guide to investor outreach lays out. Existing angels stay on the investor update list and are left out of the outreach.
Lead, followers, close. The lead's term sheet sets the price, angels and syndicates take their lines behind it, and diligence runs on the data room.
Our monthly fee covers the process, materials and outreach. The success fee is capped in the mandate and falls due only after the round has closed and the company holds the money.
What the angel investing trends mean for splitting your round
Follow-on from your angels and a syndicate asking in through an SPV both reach the lead's counsel first as documents. Settled late, they move the closing date and reopen talks with the angels who wanted in. The stake the lead fund wants decides how much is left, and three items settle the split.
Existing angels' pro rata. Total the lines your angels plan to take and size the round with them inside it, never on top of it.
SAFEs and notes. Count their converted shares in the pro forma before you offer a line to anyone new.
A new angel syndicate asking in. Send its SPV the round's documents early, or hold its line for a second close.
Outside AI and life sciences, the list of funds that can lead takes as much work as the deck and is drawn up with it. The Series A traction metrics a lead prices against decide who goes on that list.
Map the cap table and the lead list before the first meeting. The order of steps from there is in how to raise venture capital.
Three conclusions
In a priced round, angels and syndicates take their lines behind the price a lead sets. A company that treats them as anchors loses weeks reopening pro rata and conversion terms in the lead's diligence.
With nearly half of ACA-reported angel dollars in life sciences and 64% of Q3 venture money in AI, less of the money reaches a company in another sector, so the investor list sets the timeline.
US venture proceeds rose 50% in 2025 while the reported count of financings barely moved, so the companies that win a lead raise bigger rounds and nobody else gets an extra slot.
Angel investing trends 2026: questions readers ask
6 questions on investor targeting and relationships, answered by Niclas Schlopsna, Managing Partner.
01What are the current trends in angel investing?
Angel groups are writing larger cheques into fewer companies, and follow-on rounds draw bigger commitments. ACA-reported angel investment rose 12% to $491.3M in 2025, life sciences took nearly 47% of those dollars, nearly two-thirds of groups made an AI-related investment, and angel governance participation keeps falling.
02How much do angel investors typically invest?
An individual angel typically writes $25,000 to $100,000 per company, and the median US round angels take part in has stayed near $250,000 for a decade. A syndicate typically brings $200,000 to $400,000 per deal; one that pools its members invests through one vehicle, while the others leave each member to write a separate cheque. In a later round, an existing angel's amount is set by the pro rata right, if the angel holds one: enough to keep the same percentage.
03Which angel investors deploy the most capital?
Among angel groups, hybrid organisations that combine a member network with a fund: the ACA's 2026 report finds they deploy "significantly more capital" than traditional angel groups. In a priced round they come in as one counterparty with fund paperwork.
04What is the difference between angel investors and venture capital firms?
Angels invest their own money, earlier and in smaller cheques. A venture capital firm invests a fund raised from limited partners and leads the priced rounds that angels later follow.
05Is venture capital doing well right now?
Yes, by dollars. Crunchbase counted $159B of global venture funding in Q3 2026, with AI-driven companies taking 64%, and US proceeds rose to $318.6B in 2025 from $212.9B in 2024. The number of reported US financings held "essentially flat" in WilmerHale's count, 14,934 against 15,246, so the money went into larger rounds.
06When should a company raising a priced round hire a startup fundraising consultant?
Before the materials are built. An advisor brought in then sizes the round, sets which funds can lead, and settles the angels' pro rata and SAFE conversions before the first investor meeting. Brought in late, the same advisor inherits a list of funds that have already said no. spectup's mandates start at Series A and run to pre-IPO.
